News · 26 weeks42+25%
2026-03-012026-08-23
Mix1290d
- SEC Filings7(58%)
- Other3(25%)
- Earnings1(8%)
- Insider1(8%)
Latest news
25 items- INSIDERChief Financial Officer Monahan Michael P. covered exercise/tax liability with 32,357 shares, decreasing direct ownership by 2% to 1,955,280 units (SEC Form 4) (for tax liability)4 - SkinHealth Systems Inc. (0001818093) (Issuer)
- SECSEC Form DEFA14A filed by SkinHealth Systems Inc.DEFA14A - SkinHealth Systems Inc. (0001818093) (Filer)
- SECSEC Form DEF 14A filed by SkinHealth Systems Inc.DEF 14A - SkinHealth Systems Inc. (0001818093) (Filer)
- SECSEC Form 10-Q filed by SkinHealth Systems Inc.10-Q - SkinHealth Systems Inc. (0001818093) (Filer)
- SECSkinHealth Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - SkinHealth Systems Inc. (0001818093) (Filer)
- SECSEC Form PRE 14A filed by SkinHealth Systems Inc.PRE 14A - SkinHealth Systems Inc. (0001818093) (Filer)
- PRSkinHealth Systems to Report Second Quarter 2026 Financial Results on August 6, 2026LONG BEACH, Calif., July 21, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ:SKIN), a global medical aesthetics company and home to flagship brand Hydrafacial, today announced it will report second quarter 2026 financial results after market close on Thursday, August 6, 2026. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the investor relations section of the Company’s website at www.skinhealthsystems.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure In
- SECAmendment: SEC Form SCHEDULE 13G/A filed by SkinHealth Systems Inc.SCHEDULE 13G/A - SkinHealth Systems Inc. (0001818093) (Subject)
- PRSkinStylus® Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin TypesSkinStylus SteriLock MicroSystem Now the Only Microneedling Device with Indications for Facial Acne Scars, Periorbital Wrinkles, and Abdominal Scars Hydrafacial Treatment Pairing Continues to Drive Adoption of Microneedling Protocols LONG BEACH, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced that the U.S. Food and Drug Administration (FDA) has cleared the SkinStylus microneedling device for the improvement of the appearance of periorbital wrinkles in adults aged 22 years and older for all Fitzpatrick skin types. This latest clearance expands SkinStylus’ clinically supported indications and reinforces S
- SECSkinHealth Systems Inc. filed SEC Form 8-K: Other Events8-K - SkinHealth Systems Inc. (0001818093) (Filer)
- SECSkinHealth Systems Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - SkinHealth Systems Inc. (0001818093) (Filer)
- PRHydrafacial Introduces HydraScalp® with Keravive™ as Next Evolution in Scalp HealthLONG BEACH, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ:SKIN), a global medical aesthetics company and home to flagship brand Hydrafacial, today announced a refresh of its clinically supported Keravive™ scalp treatment as HydraScalp® with Keravive™, marking the next evolution in its scalp health offering. HydraScalp with Keravive is a professional, non-invasive, in-office treatment powered by Hydrafacial's proprietary Vortex-Fusion™ Technology and Keravive biomimetic peptides to deeply cleanse, exfoliate and nourish the scalp. By removing buildup and delivering targeted key ingredients to the scalp, the treatment helps create an optimal scalp environment for
- SECAmendment: SkinHealth Systems Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K/A - SkinHealth Systems Inc. (0001818093) (Filer)
- SECSkinHealth Systems Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - SkinHealth Systems Inc. (0001818093) (Filer)
- SECSEC Form 10-Q filed by SkinHealth Systems Inc.10-Q - SkinHealth Systems Inc. (0001818093) (Filer)
- SECSkinHealth Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - SkinHealth Systems Inc. (0001818093) (Filer)
- PRSkinHealth Systems Reports First Quarter 2026 Financial ResultsLONG BEACH, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ:SKIN) ("SkinHealth Systems" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2026 ("Q1 2026"). "First quarter results reflect the strength of the business. We delivered revenue within our guidance range, significantly outperformed on adjusted EBITDA, and continued to expand margins through disciplined execution. "While the market remains challenging and we are lowering our full-year revenue outlook, the fundamentals are intact. The installed base is growing, the brand is strong, and we are taking direct action to improve execut
- SECSkinHealth Systems Inc. filed SEC Form 8-K: Leadership Update8-K - SkinHealth Systems Inc. (0001818093) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by SkinHealth Systems Inc.SCHEDULE 13G/A - SkinHealth Systems Inc. (0001818093) (Subject)
- PRSkinHealth Systems to Report First Quarter 2026 Financial Results on May 7, 2026LONG BEACH, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. ((formerly The Beauty Health Company, NASDAQ:SKIN), a global medical aesthetics company, today announced it will report first quarter 2026 financial results after market close on Thursday, May 7, 2026. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the investor relations section of the Company's website at www.skinhealthsystems.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure Informa
- SECSEC Form DEF 14A filed by SkinHealth Systems Inc.DEF 14A - SkinHealth Systems Inc. (0001818093) (Filer)
- INSIDERSEC Form 3 filed by new insider Beattie Edward Scott3 - SkinHealth Systems Inc. (0001818093) (Issuer)
- INSIDERSEC Form 3 filed by new insider Shridharani Sachin Mahavir3 - SkinHealth Systems Inc. (0001818093) (Issuer)
- INSIDERSEC Form 3 filed by new insider Tripp Kenneth Robert3 - SkinHealth Systems Inc. (0001818093) (Issuer)
- SECThe Beauty Health Company filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits8-K - SkinHealth Systems Inc. (0001818093) (Filer)
SKIN FAQ
7 questionsWhat does SkinHealth Systems Inc. do?
Edge Systems, LLC designs, develops, manufactures, markets, and sells aesthetic technologies and products. It offers hydradermabrasion system that enhances the skin to cleanse, exfoliate, extract, and hydrate simultaneously; Hydraglucan Intense Hydration Booster, a customization for the HydraFacial treatment exfoliates the skin by improving cell renewal and delivers ingredients, including hyaluronic acid, glucan, and betaine to hydrate the skin and provide anti-aging benefits; HydraFacial Daily Essentials, which provides detoxification, rejuvenation, and protection of skin; crystal...Where does SKIN stock trade?
SkinHealth Systems Inc. (SKIN) is listed on NASDAQ.What sector and industry is SKIN in?
SkinHealth Systems Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did SkinHealth Systems Inc. go public?
SkinHealth Systems Inc. (SKIN) completed its IPO in 2020.What are analysts saying about SKIN?
SkinHealth Systems Inc. has had 8 recent analyst actions on file. The most recent action was from Roth Capital: Buy with a $350.00 price target on 2025-09-19. Recent price targets range from $150.00 to $350.00.What companies are similar to SKIN?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare SKIN side-by-side with any of them on Quantisnow.How can I track SKIN on Quantisnow?
Quantisnow aggregates SkinHealth Systems Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SKIN to receive live email and push alerts on every new disclosure.